This site is intended for healthcare professionals
Micrograph of bone marrow rendered in pinks and purples

Find disease awareness content and relevant supporting materials

    Learning Zone CME Events News Trials Guidelines Journals
    Filter results
    Sort by:
    Relevance
    to
    New CAR-T cell method may allow some cancer patients to skip chemotherapy-
    News
    02/05/26

    New CAR-T cell method may allow some cancer patients to skip chemotherapy

    By Nancy LapidMay 1 (Reuters) - We also report on a new use for artificial intelligence that could help eliminate some racial inequities in heart disease diagnoses.MODIFIED

    Latest industry news
    News
    14/05/26

    AI patch identifies possible causes of unexplained infertility

    (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidMay 13 (Reuters) - We also report on

    Expert interviews
    06/05/26

    Understanding the NF1 journey

    Patient and expert perspectives

    Event
    18/05/26

    DP Test

    Researchers identify antibodies that may prevent and treat measles infections-
    News
    09/05/26

    Researchers identify antibodies that may prevent and treat measles infections

    (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidMay 8 (Reuters) - We also report on a

    Opinion articles and videos from experts around the world!
    13/05/26

    5

    Microscopic image of tissue showing purple cells on a pink background.
    06/05/26

    Transcript: Shaping NF1 care: Johns Hopkins biorepository

    Read a transcript of Christine Pratilas discussing the Johns Hopkins NF1 biorepository, genomic data sharing, and research impact in NF1.

    Health Rounds: Researchers gain new insight into how psychedelics affect the brain-
    News
    07/05/26

    Health Rounds: Researchers gain new insight into how psychedelics affect the brain

    (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidMay 6 (Reuters) - We also report on t

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    24/01/25

    EU Approves Lazcluze for NSCLC

    European Commission approves Lazcluze and Rybrevant for first-line treatment of EGFR-mutated NSCLC.

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    15/01/25

    Positive Results for Libtayo

    Positive results from Phase III trial of Libtayo in cutaneous squamous cell carcinoma after surgery. Regeneron.

    See more